NEM - Paulson & Co. closes stake in Newmont boosts Horizon Therapeutics stake
2023-11-15 10:12:31 ET
More on Madrigal, Newmont, etc.
- Madrigal Pharmaceuticals: Preparing For Resmetirom's Commercialization In 2024
- Madrigal Pharmaceuticals Bolstered By $500 Million Equity Infusion Is A 'Buy' Into 2024
- Newmont: Margins Improve, But Production Below Plan
- Madrigal adds former Sanofi executive as commercial chief
For further details see:
Paulson & Co. closes stake in Newmont, boosts Horizon Therapeutics stake